Preview

Meditsinskiy sovet = Medical Council

Advanced search

Biliary sludge: solved and unresolved issues

https://doi.org/10.21518/2079-701X-2018-14-90-96

Abstract

The article presents international materials on studying the issue of biliary sludge (BS). The authors also share their own data resulting from conducted studies, where the first group included 1107 patients with BS; the second – 208 patients with different forms of BS; the third group – 40 patients with regular course of BS, in the absence of pharmacological influence; the fourth group – 60 patients (20 patients for each type of BS) with UDCA Exhol 500 mg No. 50 and antispasmodic agent Sparex 200 mg No 30. Intake of Exhol at an initial dose of 15 mg/kg/day was effective in 97% of cases and BS elimination was achieved in 12 weeks. The BS elimination rate depended on its type (1st – 4 weeks, 2–3rd types – 8–12 weeks).

About the Authors

O. N. Minushkin
Central State Medical Academy of the Administrative Department of the President of the Russian Federation
Russian Federation


E. G. Burdina
Outpatient Clinic No 3 of the Administrative Department of the President of the Russian Federation
Russian Federation


E. V. Novozhenova
Outpatient Clinic No 1 of the Administrative Department of the President of the Russian Federation
Russian Federation


References

1. Ilchenko AA. Gallbladder and bile duct disorders, 2011, 358.

2. Mansurov HH. Gallstone disease, 1991, 222 pages.

3. Ilchenko AA. Gallstone disease classification. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii, Koloproktologii, 2002, 5, p. 99.

4. Minushkin ON, Burdina EG, Novozhenova EV. Biliary Sludge. Epidemiology, risk factors for formation, diagnosis, treatment approaches. Meditsinskiy Alfavit, 19, 2017, 2.

5. Novozhenova EV. Biliary sludge: risk factors, diagnosis, treatment, prognosis, diss. of Ph.D., 2017.

6. Ilchenko AA, Delyukina OV. Clinical significance of biliary sludge. Journal Consilium Medicum, 2005, 2, 28-32.

7. Minushkin ON, et al. Biliary Sludge: diagnosis and treatment in outpatient clinic settings. Journal Eksperimentalnaya i Klinicheskaya Gastroenterologiya, 2013, 9, 14-20.

8. Maev IV, et al. Immediacy of the therapy of patients with biliary sludge. Journal Klinicheskiye Perspektivy Gastroenterologii, Gepatologii, 2013, 1, 3-10

9. Vikhrova ТV. Biliary sludge and its clinical significance. Extended abstract of PhD in medicine Dissertation. Moscow, 2003.

10. Minushkin ON, et al. The hepatopathy and the role of Laennec in the treatment. Methodical guide, 2017, 11 pp.

11. Minushkin ON, Elizavetina GA, Ivanova OI, Shaposhnikova OF. Ursodeoxycholic acid in the treatment of patients with biliary sludge, Journal Effektivnaya Farmakoterapiya, 2012, 3, p. 10-13.


Review

For citations:


Minushkin ON, Burdina EG, Novozhenova EV. Biliary sludge: solved and unresolved issues. Meditsinskiy sovet = Medical Council. 2018;(14):90-96. (In Russ.) https://doi.org/10.21518/2079-701X-2018-14-90-96

Views: 777


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)